openPR Logo
Press release

Lawsuit filed for Investors in shares of Rivian Automotive, Inc. (NASDAQ: RIVN)

03-16-2022 02:13 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

A lawsuit was filed on behalf of investors in Rivian Automotive, Inc. (NASDAQ: RIVN) shares.

A lawsuit was filed on behalf of investors in Rivian Automotive, Inc. (NASDAQ: RIVN) shares.

An investor, who purchased shares of Rivian Automotive, Inc. (NASDAQ: RIVN), filed a lawsuit over alleged violations of Federal Securities Laws by Rivian Automotive, Inc. in connection with Rivian's Initial Public Offering ("IPO") on November 10, 2021

Investors who purchased shares of Rivian Automotive, Inc. (NASDAQ: RIVN) have certain options and for certain investors are short and strict deadlines running. Deadline: May 6, 2022. NASDAQ: RIVN investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

According to the Registration Statement, the "R1T and R1S introduce our brand to the world and will serve as our flagship vehicles as we continue to expand our offerings."
Rivian's focus on its reputation for transparency and devotion to its customers, along with Rivian's R1T and R1S, including the large number of preorders and potential for increased demand were key selling points to IPO investors.

On January 11, 2022, Rivian announced its COO, Rod Copes had stepped down.

Shares of Rivian Automotive, Inc. (NASDAQ: RIVN) declined from $123.40 per share on December 8, 2021, to as low as $55.10 per share on January 24, 2022.

The plaintiff alleges on behalf of purchasers of Rivian Automotive, Inc. (NASDAQ: RIVN) common shares, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that the IPO Registration Statement's representations were materially inaccurate, misleading, and/or incomplete because they failed to disclose, among other things, that the R1T and R1S were underpriced to such a degree that Rivian would have to raise prices shortly after the IPO and that these price increases would tarnish Rivian's reputation as a trustworthy and transparent company and would put a significant number of the existing backlog of 55,400 preorders along with future preorders in jeopardy of cancellation.

Those who purchased shares of Rivian Automotive, Inc. (NASDAQ: RIVN) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Lawsuit filed for Investors in shares of Rivian Automotive, Inc. (NASDAQ: RIVN) here

News-ID: 2579446 • Views:

More Releases from Shareholders Foundation

Lawsuit DEADLINE Alert: Investors who lost money with Stride, Inc. (NYSE: LRN) shares should contact the Shareholders Foundation
Lawsuit DEADLINE Alert: Investors who lost money with Stride, Inc. (NYSE: LRN) s …
An investor, who purchased shares of Stride, Inc. (NYSE: LRN), filed a lawsuit over alleged violations of Federal Securities Laws by Stride, Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of Stride, Inc. (NYSE: LRN) have certain options and for certain investors are short and strict deadlines running. Deadline: January 12, 2026. NYSE: LRN investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858)
Lawsuit Alert: Investors who lost money with James Hardie Industries plc (NYSE: JHX) should contact the Shareholders Foundation
Lawsuit Alert: Investors who lost money with James Hardie Industries plc (NYSE: …
An investor, who purchased shares of James Hardie Industries plc (NYSE: JHX), filed a lawsuit over alleged violations of Federal Securities Laws by James Hardie Industries plc in connection with certain allegedly false and misleading statements. Investors who purchased shares of James Hardie Industries plc (NYSE: JHX) have certain options and for certain investors are short and strict deadlines running. Deadline: December 23, 2025. NYSE: JHX investors should contact the Shareholders
Investigation announced for Long-Term Investors in SelectQuote, Inc. (NYSE: SLQT)
Investigation announced for Long-Term Investors in SelectQuote, Inc. (NYSE: SLQT …
An investigation on behalf of current long-term investors in shares of SelectQuote, Inc. (NYSE: SLQT) concerning potential breaches of fiduciary duties by certain directors and officers of SelectQuote, Inc. was announced. Investors who are current long term investors in SelectQuote, Inc. (NYSE: SLQT) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term
Lawsuit filed for Investors who lost money with shares of MoonLake Immunotherapeutics (NASDAQ: MLTX)
Lawsuit filed for Investors who lost money with shares of MoonLake Immunotherape …
An investor, who purchased shares of MoonLake Immunotherapeutics (NASDAQ: MLTX), filed a lawsuit over alleged violations of Federal Securities Laws by MoonLake Immunotherapeutics in connection with certain allegedly false and misleading statements. Investors who purchased a significant amount of shares of MoonLake Immunotherapeutics (NASDAQ: MLTX) between March 10, 2024 and September 29, 2025, have certain options and for certain investors are short and strict deadlines running. Deadline: December 15, 2025. NASDAQ:

All 5 Releases


More Releases for Rivian

Shared Electric Vehicle Platform Market Is Going to Boom |• Tesla • Rivian
Worldwide Market Reports has released a new in-depth research study on the "Shared Electric Vehicle Platform Market," highlighting strong growth potential in the coming years. The report delivers a structured and data-driven analysis of the market landscape, combining robust research methodology, market sizing, validated data modeling, and insights sourced from reliable primary and secondary channels. The study thoroughly examines key market aspects, including growth drivers, restraints, challenges, emerging opportunities, technological advancements,
Electric Commercial Vehicle Market is Booming Worldwide | • Tesla • Rivian
Worldwide Market Reports has added a new research study on "Electric Commercial Vehicle Market" is projected to experience substantial growth in the coming years. This report provides a comprehensive analysis of the market landscape using an integrated approach that includes research methodology, market size evaluation, data compilation, and insights gathered from multiple credible sources. The study covers critical market elements such as market dynamics, drivers, restraints, challenges, threats, growth opportunities, development
EV Software Market Current Status and Future Prospects | Rivian, BMW
According to HTF Market Intelligence, the Global EV Software market to witness a CAGR of 18.4% during the forecast period (2025-2030). The Latest Released EV Software Market Research assesses the future growth potential of the EV Software market and provides information and useful statistics on market structure and size. This report aims to provide market intelligence and strategic insights to help decision-makers make sound investment decisions and identify potential gaps and
Green Mobility Market is Thriving Worldwide |Rivian,Bird,Ola Electric
HTF MI just released the Global Green Mobility Market Study, a comprehensive analysis of the market that spans more than 143+ pages and describes the product and industry scope as well as the market prognosis and status for 2025-2032. The marketization process is being accelerated by the market study's segmentation by important regions. The market is currently expanding its reach. Major Manufacturers are covered: Tesla Inc. (USA), BYD Co. Ltd. (China),
Electric Passenger Cars Market Is Booming So Rapidly | Hyundai, Rivian, Ford
The Global Electric Passenger Cars Market Size is estimated at $304.4 Billion in 2025 and is forecast to register an annual growth rate (CAGR) of 8.1% to reach $613.6 Billion by 2034. The latest study released on the Global Electric Passenger Cars Market by USD Analytics Market evaluates market size, trend, and forecast to 2034. The Electric Passenger Cars market study covers significant research data and proofs to be a handy
Electric SUV Market Is Booming Worldwide | Nissan, Rivian, Kia
The Global Electric SUV Size is estimated at $351.8 Billion in 2025 and is forecast to register an annual growth rate (CAGR) of 12.6% to reach $1023.5 Billion by 2034. The latest study released on the Global Electric SUV Market by USD Analytics Market evaluates market size, trend, and forecast to 2034. The Electric SUV market study covers significant research data and proofs to be a handy resource document for